Its primary licensed indication in the United States, under the brand name Egrifta is the reduction of excess visceral adipose tissue (VAT) in people living with HIV-associated lipodystrophy
and NCT03693430, longterm WM), ~5,000 participants are being randomly assigned to receive semaglutide 2.4 mg once weekly subcutaneously versus placebo
Benefits from CoQ10 and L-carnitine supplementation typically require several weeks to months of consistent use to become apparent
Introduction GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) have revolutionized weight management and type 2 diabetes treatment, helping over 1.6 million adults in England, Wales, and Scotland between early 2024 and early 2025
It exists in almost every cell of the human body, acting as a primary shield against oxidative stress
Renal and hepatic function